共 99 条
- [1] Patel IH(1981)Pharmacokinetics of ceftriaxone in humans Antimicrob Agents Chemother. 20 634-641
- [2] Chen S(1984)Antimicrobial activity of ceftriaxone: a review Am J Med. 77 3-11
- [3] Parsonnet M(1984)Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment Antimicrob Agents Chemother. 25 438-442
- [4] Hackman MR(1983)Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis Antimicrob Agents Chemother. 24 529-532
- [5] Brooks MA(1988)Reversible ceftriaxone-associated biliary pseudolithiasis in children Lancet. 2 1411-1413
- [6] Konikoff J(2000)Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children J Clin Ultrasound. 28 166-168
- [7] Kaplan SA(2000)Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children Eur J Pediatr Surg. 10 368-371
- [8] Cleeland R(2013)Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics Bone Marrow Transplant. 48 452-458
- [9] Squires E(1986)Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy Pediatr Infect Dis. 5 708-710
- [10] Patel IH(2005)Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature Pharmacotherapy. 25 1389-1395